Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00399-020-00666-y http://scihub22266oqcxt.onion/10.1007/s00399-020-00666-y 32025785!ä!32025785 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Herzschrittmacherther+Elektrophysiol 2020 ; 31 (1): 48-54 Nephropedia Template TP {{tp|p=32025785|t=2020. Long- und Short-QT-Syndrome : Notfalltherapie und Sekundarprophylaxe |pdf=|usr=}}{{32025785}} gab.com Text Long- und Short-QT-Syndrome : Notfalltherapie und Sekundarprophylaxe JO: Herzschrittmacherther Elektrophysiol http://www.kidney.de/pget.php?&tw=1&pmid=32025785 #FOAvip Long QT syndrome (LQTS) is a rare inherited or acquired channelopathy associated with a relevant mortality if left untreated. Therapy can reduce the sudden cardiac death (SCD) rate significantly. Of 17 subtypes, LQTS1-3 are the most common. Clinical presentation ranges from asymptomatic patients to torsade de pointes (TdP) and SCD. Emergency therapy includes defibrillation, administration of magnesium, betablockers and temporary pacing and sedation. Secondary prevention is based on betablocker therapy and implantation of an implantable cardioverter-defibrillator (ICD), if appropriate. Short QT syndrome (SQTS) is a rare channelopathy that manifests as SCD in 34%. So far 250 cases with mutations in 8 genes have been reported. ICDs are the only reliable protection against SCD. Drug therapy is based on hydroquinidine. Further therapeutic options exist for certain subtypes of both diseases. Patients should be referred to specialized centers. Twit Text FOAVip Long- und Short-QT-Syndrome : Notfalltherapie und Sekundarprophylaxe ????Herzschrittmacherther Elektrophysiol http://www.kidney.de/pget.php?&tw=1&pmid=32025785 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32025785 #FOAvip English Wikipedia <ref>{{Cite pmid|32025785}}</ref> Long- und Short-QT-Syndrome : Notfalltherapie und Sekundarprophylaxe #MMPMID32025785 Horn N; Rub N; Wolpert C Herzschrittmacherther Elektrophysiol 2020[Mar]; 31 (1): 48-54 PMID32025785show ga Long QT syndrome (LQTS) is a rare inherited or acquired channelopathy associated with a relevant mortality if left untreated. Therapy can reduce the sudden cardiac death (SCD) rate significantly. Of 17 subtypes, LQTS1-3 are the most common. Clinical presentation ranges from asymptomatic patients to torsade de pointes (TdP) and SCD. Emergency therapy includes defibrillation, administration of magnesium, betablockers and temporary pacing and sedation. Secondary prevention is based on betablocker therapy and implantation of an implantable cardioverter-defibrillator (ICD), if appropriate. Short QT syndrome (SQTS) is a rare channelopathy that manifests as SCD in 34%. So far 250 cases with mutations in 8 genes have been reported. ICDs are the only reliable protection against SCD. Drug therapy is based on hydroquinidine. Further therapeutic options exist for certain subtypes of both diseases. Patients should be referred to specialized centers. |*Long QT Syndrome/prevention & control[MESH] |Arrhythmias, Cardiac[MESH] |Electrocardiography[MESH] |Emergency Treatment[MESH] |Humans[MESH]Long- und Short-QT-Syndrome : Notfalltherapie und Sekundarprophylaxe (epmc).pdf DeepDyve Pubget Overpricing